Abstract
ObjectivesGiven the platinum sensitivity of BRCA 1/2-mutated high-grade serous ovarian cancers (HGSC), there is uncertainty about the relative benefits of primary cytoreductive surgery (PCS) versus neoadjuvant chemotherapy (NACT) in this...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
